Page last updated: 2024-08-24

etiroxate and Hyperlipoproteinemia Type II

etiroxate has been researched along with Hyperlipoproteinemia Type II in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kalinová, M; Sobotka, L; Zadák, Z1
Schwandt, P; Weisweiler, P1
Banz, H; Gall, FP2

Trials

2 trial(s) available for etiroxate and Hyperlipoproteinemia Type II

ArticleYear
[Dose-response comparison with etiroxat HCl in hyperlipoproteinemias types IIa and IIb].
    Medizinische Klinik, 1980, Jan-04, Volume: 75, Issue:1

    Topics: Anticholesteremic Agents; Dose-Response Relationship, Drug; Female; Humans; Hyperlipoproteinemia Type II; Male; Thyroxine

1980
[Therapy of hyperlipoproteinemia type IIa and IIb with etiroxate-HCl. Dose-response comparison].
    Fortschritte der Medizin, 1979, Nov-08, Volume: 97, Issue:42

    Topics: Cholesterol; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Hyperlipoproteinemia Type II; Male; Thyroxine; Triglycerides

1979

Other Studies

2 other study(ies) available for etiroxate and Hyperlipoproteinemia Type II

ArticleYear
[Etiroxate treatment for hyperlipoproteinaemia type IIa and IIb (author's transl)].
    Casopis lekaru ceskych, 1982, May-14, Volume: 121, Issue:19

    Topics: Adult; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Thyroxine

1982
Effects of etiroxate on low density and high density lipoproteins in hypercholesterolemic patients.
    Atherosclerosis, 1981, Volume: 39, Issue:1

    Topics: Adult; Apolipoproteins; Cholesterol; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Thyroxine; Triglycerides

1981